Schedule 13D ownership disclosure

Bicara Therapeutics Inc

Security class unavailable · CUSIP: 055477103

Event date: 2024-09-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,761,359
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-102046
Form type
SC 13D
Filer
Enavate Sciences GP, LLC
CIK
CIK 1953107
Filed
Sep 23, 2024
Reporting period
Sep 16, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub